Endobalansas - Company finances
|
EUR
|
2024
From: 2024-05-10
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 5,199 | 10,715 |
| Profit before tax | 4,629 | 3,848 |
| Net profit | 4,629 | 3,617 |
| Equity | 4,719 | 8,336 |
| Liabilities | 0 | 600 |
| Non-current assets | 0 | 1,132 |
| Current assets | 4,719 | 7,804 |
| Total assets | 4,719 | 8,936 |
|
Taxes paid
|
||
| STI taxes | 64 | 43 |
|
Financial indicators
|
||
| Revenue change y/y | - | +106.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 98.1% | 40.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.1% | 43.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 89.0% | 33.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 89.0% | 35.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Endobalansas - Social security debts
The company had no debts to Sodra
Endobalansas - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Endobalansas, MB (code 306754953) is a Lithuanian small partnership engaged in general medical practice activities. In the latest financial year 2025, the company generated revenue of EUR 10.7K, up 106.1% year on year from EUR 5.2K in 2024. Net profit for 2025 was EUR 3.6K, compared with EUR 4.6K in 2024, while profit before tax reached EUR 3.8K. The 2025 profit margin was 33.8%, indicating that the business remained profitable despite lower earnings than the previous year. Over the two-year period, revenue expanded strongly, while profit moderated from the exceptionally high 2024 level. At the end of 2025, total assets stood at EUR 8.9K and equity at EUR 8.3K, with liabilities of EUR 600. The equity ratio was 93.3%, debt-to-equity 0.07, and asset turnover 1.20x. Return on equity was 43.4% and return on assets 40.5%.